| Ident. | Authors (with country if any) | Title |
|---|
| 000056 (2020) |
Paolo Verdecchia ; Gianpaolo Reboldi ; Claudio Cavallini ; Giovanni Mazzotta ; Fabio Angeli | [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]. |
| 000147 (2020) |
Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Götte [Canada] | The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. |
| 000312 (2020) |
Guido Iaccarino [Italie] ; Claudio Borghi [Italie] ; Arrigo F. G. Cicero [Italie] ; Claudio Ferri [Italie] ; Pietro Minuz [Italie] ; Maria Lorenza Muiesan [Italie] ; Paolo Mulatero [Italie] ; Giuseppe Mulè [Italie] ; Giacomo Pucci [Italie] ; Massimo Salvetti [Italie] ; Carmine Savoia [Italie] ; Leonardo Alberto Sechi [Italie] ; Massimo Volpe [Italie] ; Guido Grassi [Italie] | Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension |
| 000313 (2020) |
Ka-Tim Choy [République populaire de Chine] ; Alvina Yin-Lam Wong [République populaire de Chine] ; Prathanporn Kaewpreedee [République populaire de Chine] ; Sin Fun Sia [République populaire de Chine] ; Dongdong Chen [République populaire de Chine] ; Kenrie Pui Yan Hui [République populaire de Chine] ; Daniel Ka Wing Chu [République populaire de Chine] ; Michael Chi Wai Chan [République populaire de Chine] ; Peter Pak-Hang Cheung [République populaire de Chine] ; Xuhui Huang [République populaire de Chine] ; Malik Peiris [République populaire de Chine] ; Hui-Ling Yen [République populaire de Chine] | Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro |
| 000314 (2020) |
Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Emma Woolner [Canada] ; Jason K. Perry [États-Unis] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Gotte [Canada] | Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. |
| 000450 (2020) |
Subramanian Boopathi [Chili] ; Adolfo B. Poma [Pologne] ; Ponmalai Kolandaivel [Inde] | Novel 2019 Coronavirus Structure, Mechanism of Action, Antiviral drug promises and rule out against its treatment. |
| 000489 (2020) |
Kaihao Liang | Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS |
| 000517 (2020) |
Ying Yan [République populaire de Chine] ; Le Chang [République populaire de Chine] ; Lunan Wang [République populaire de Chine] | Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures. |
| 000536 (2020) |
M. Bizzarri [Italie] ; A S Laganà ; D. Aragona ; V. Unfer | Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2? |
| 000541 (2020) |
Shuai Xia [République populaire de Chine] ; Meiqin Liu [République populaire de Chine] ; Chao Wang [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Qiaoshuai Lan [République populaire de Chine] ; Siliang Feng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Lanying Du [États-Unis] ; Shuwen Liu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Fei Sun [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Lu Lu [République populaire de Chine] | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
| 000B18 (2019) |
Seri Jo ; Suwon Kim ; Dong Hae Shin ; Mi-Sun Kim | Inhibition of SARS-CoV 3CL protease by flavonoids |
| 000B94 (2019) |
Xianfeng Lin ; Houguang Shi ; Weixing Zhang ; Zongxing Qiu ; Zheng Zhou ; Fabian Dey ; Sheng Zhong ; Hongxia Qiu ; Jianxun Xie ; Xue Zhou ; Guang Yang ; Guozhi Tang ; Hong C. Shen ; Wei Zhu | A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles. |
| 000C31 (2018) |
Cy V. Credille [États-Unis] ; Benjamin L. Dick [États-Unis] ; Christine N. Morrison [États-Unis] ; Ryjul W. Stokes [États-Unis] ; Rebecca N. Adamek [États-Unis] ; Nicholas C. Wu [États-Unis] ; Ian A. Wilson [États-Unis] ; Seth M. Cohen [États-Unis] | Structure-Activity Relationships in Metal-Binding Pharmacophores for Influenza Endonuclease. |
| 000C32 (2018) |
Liangzhong Lim [Singapour] ; Garvita Gupta [Singapour] ; Amrita Roy [Singapour] ; Jian Kang [Singapour] ; Shagun Srivastava [Singapour] ; Jiahai Shi ; Jianxing Song [Singapour] | Structurally- and dynamically-driven allostery of the chymotrypsin-like proteases of SARS, Dengue and Zika viruses |
| 000C36 (2018) |
Zhou Shen [République populaire de Chine] ; Gang Ye [République populaire de Chine] ; Feng Deng [République populaire de Chine] ; Gang Wang [République populaire de Chine] ; Min Cui [République populaire de Chine] ; Liurong Fang [République populaire de Chine] ; Shaobo Xiao [République populaire de Chine] ; Zhen F. Fu [République populaire de Chine, États-Unis] ; Guiqing Peng [République populaire de Chine] | Structural Basis for the Inhibition of Host Gene Expression by Porcine Epidemic Diarrhea Virus nsp1 |
| 000C51 (2018) |
Hsu-Feng Chu [Taïwan] ; Chiao-Che Chen [Taïwan] ; David C. Moses [Taïwan] ; Yau-Hung Chen [Taïwan] ; Chao-Hsiung Lin [Taïwan] ; Ying-Chieh Tsai [Taïwan] ; Chi-Yuan Chou [Taïwan] | Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine |
| 000C95 (2018) |
Rakhi Gawali [Inde] ; Jay Trivedi [Inde] ; Sujit Bhansali [Inde] ; Raghunath Bhosale [Inde] ; Dhiman Sarkar [Inde] ; Debashis Mitra [Inde] | Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors. |
| 000D04 (2018) |
Lisa E. Gralinski [États-Unis] ; Timothy P. Sheahan [États-Unis] ; Thomas E. Morrison [États-Unis] ; Vineet D. Menachery [États-Unis] ; Kara Jensen [États-Unis] ; Sarah R. Leist [États-Unis] ; Alan Whitmore [États-Unis] ; Mark T. Heise [États-Unis] ; Ralph S. Baric [États-Unis] | Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis |
| 000D45 (2017) |
Woo-Jin Shin [États-Unis] ; Baik Lin Seong [Corée du Sud] | Type II transmembrane serine proteases as potential target for anti-influenza drug discovery. |
| 000D57 (2017) |
Cheng-Wei Yang [République populaire de Chine] ; Yue-Zhi Lee [République populaire de Chine] ; Hsing-Yu Hsu [République populaire de Chine] ; Chuan Shih [République populaire de Chine] ; Yu-Sheng Chao [République populaire de Chine] ; Hwan-You Chang [République populaire de Chine] ; Shiow-Ju Lee [République populaire de Chine] | Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity. |
| 000E04 (2017) |
Manal Alfuwaires ; Abdallah Altaher ; Mahmoud Kandeel | Molecular Dynamic Studies of Interferon and Innate Immunity Resistance in MERS CoV Non-Structural Protein 3. |
